AI assistant
CASTLE BIOSCIENCES INC — Director's Dealing 2021
May 20, 2021
32601_dirs_2021-05-20_ab30b014-9d4d-4833-99ff-bdd8c096962e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CASTLE BIOSCIENCES INC (CSTL)
CIK: 0001447362
Period of Report: 2021-05-18
Reporting Person: MAETZOLD DEREK J (Director, Pres. & Chief Exec. Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-18 | Common Stock | S | 100 | $60.09 | Disposed | 555919 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 156460 | Indirect |
| Common Stock | 179300 | Indirect |
| Common Stock | 166700 | Indirect |
Footnotes
F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on December 11, 2020
F2: Held by DJM Grantor Retained Annuity Trust No. 1 of which the Reporting Person is the trustee and beneficiary.
F3: Held by The Maetzold Descendants 2020 Trust of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and their children are beneficiaries.
F4: Held by Derek Maetzold 2020 Irrevocable Trust of which the Reporting Person is the trustee and his children are beneficiaries.